Roch Toralf, Schulz Christian, Jung Friedrich, Ma Nan, Lendlein Andreas
Institute of Polymer Science and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Helmholtz-Zentrum Geesthacht, Teltow, Germany Helmholtz Virtual Institute - Multifunctional Biomaterials for Medicine, Teltow and Berlin, Germany.
Institute of Polymer Science and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Helmholtz-Zentrum Geesthacht, Teltow, Germany.
Clin Hemorheol Microcirc. 2014;57(2):203-12. doi: 10.3233/CH-141831.
With the worldwide increase of atherosclerosis, the need for new engineered patient specific implants such as stents or vascular grafts is still emerging. Recently, very smooth poly(ether imide) (PEI) films were, based on their hemocompatibility and compatibility with endothelial cells, suggested as potential biomaterial for cardiovascular applications. In atherosclerosis, immune mechanisms such as complement activation, but also cellular responses such as monocytes and neutrophils activation, can mediate the inflammatory response. Therefore, it is important that the implant material itself does not trigger the inflammatory response. Early immune mechanisms - e.g. macrophage activation, complement induction, generation of reactive oxygen species (ROS), and the secretion of inflammatory cytokines by leukocytes - could potentiate the inflammatory responses, and may thereby alter endothelial cells behaviour or facilitate platelet activation. Therefore, it is important to evaluate the immuno-compatibility of PEI-films. The PEI-films were fabricated from commercially available PEI, which was dissolved in dichloromethane and pulled out on a cleaned, smooth glass surface and subsequently, solvent residues were removed during the drying procedure. Using a murine macrophage reporter cell line possible material bound microbial contaminations and material intrinsic immuno-stimulatory properties were investigated. The macrophages were viable after adhering on the PEI-films and did not show signs of activation, indicating that the used PEI-film was free of microbial contaminations. To determine whether PEI-films induced complement activation, the release of C5a in pooled human plasma was analyzed. The detected C5a levels did not differ between PEI-films and tissue culture plates (TCP), which served as control material. Furthermore, in whole human blood, the generation of ROS as well as the cytokine production were investigated by flow cytometry and by multiplex bead arrays, respectively. The production of IL-6 and TNF-α as well as the generation of ROS by immune cells of the whole blood was not induced upon contact with PEI-films. The immunological evaluation of PEI-films revealed that no substantial activation of the investigated early immune mechanisms occurred. Altogether, this data demonstrate that PEI is immuno-compatible and from that perspective may be a suitable biomaterial for cardiovascular applications.
随着全球动脉粥样硬化发病率的上升,对新型工程化的患者特异性植入物(如支架或血管移植物)的需求仍在不断涌现。最近,基于其血液相容性以及与内皮细胞的兼容性,表面非常光滑的聚醚酰亚胺(PEI)薄膜被认为是心血管应用的潜在生物材料。在动脉粥样硬化中,免疫机制如补体激活,以及细胞反应如单核细胞和中性粒细胞的激活,均可介导炎症反应。因此,植入材料本身不引发炎症反应至关重要。早期免疫机制,如巨噬细胞激活、补体诱导、活性氧(ROS)生成以及白细胞分泌炎性细胞因子,可能会增强炎症反应,进而可能改变内皮细胞行为或促进血小板激活。因此,评估PEI薄膜的免疫相容性很重要。PEI薄膜由市售PEI制成,将其溶解于二氯甲烷中,在清洁光滑的玻璃表面拉出,随后在干燥过程中去除溶剂残留。使用小鼠巨噬细胞报告细胞系研究了可能与材料结合的微生物污染以及材料固有的免疫刺激特性。巨噬细胞在附着于PEI薄膜后仍具活力,且未显示激活迹象,表明所用PEI薄膜无微生物污染。为确定PEI薄膜是否诱导补体激活,分析了人混合血浆中C5a的释放情况。PEI薄膜与作为对照材料的组织培养板(TCP)之间检测到的C5a水平无差异。此外,在全血中,分别通过流式细胞术和多重微珠阵列研究了ROS的生成以及细胞因子的产生。全血免疫细胞在与PEI薄膜接触后未诱导IL-6和TNF-α的产生以及ROS的生成。PEI薄膜的免疫学评估显示,所研究的早期免疫机制未发生实质性激活。总之,这些数据表明PEI具有免疫相容性,从这个角度来看,它可能是心血管应用的合适生物材料。